Biogen Scheduled to Report Q3 2026 Earnings on October 28
Biogen (BIIB) is set to release its third-quarter 2026 financial results on Wednesday, October 28, prior to the market opening. The company's performance will be closely watched as it navigates shifting revenue streams and earnings expectations. Market consensus estimates project a quarterly revenue of $2.63 billion, representing a 3.5% increase year-over-year. However, earnings per share (EPS) are expected to decline significantly, with an estimated $1.98, marking a 58.8% decrease compared to the same period last year.
Tickers: $BIIB